Back

1 October 2025

The ITA acknowledges the CAS awards sanctioning weightlifters Revaz Davitadze and Gurami Giorbelidze

The Appeals Arbitration Division of the Court of Arbitration for Sport (CAS) has overturned, upon appeal by the ITA, the decisions issued by the Disciplinary Committee of the Georgian Anti-Doping Agency (GADA) and confirmed that Georgian weightlifters Revaz Davitadze and Gurami Giorbelidze have each committed anti-doping rule violations (ADRVs) for the presence and use of a prohibited substance and has sanctioned them with four years of ineligibility and a disqualification of competitive results.

¹ A report from a WADA-accredited laboratory that, consistent with the International Standard for Laboratories, establishes in a sample the presence of a prohibited substance or its metabolites or markers or evidence of the use of a prohibited method.

² ‘No Fault or Negligence’ is defined as “The Athlete or other Person’s establishing that he or she did not know or suspect, and could not reasonably have known or suspected even with the exercise of utmost caution, that he or she had Used or been administered the Prohibited Substance or Prohibited Method or otherwise violated an anti-doping rule”.

³ The default period of ineligibility for an anti-doping rule violation for the presence of a non-specified prohibited substance such as Ostarine is four years, unless the athlete establishes, for instance ‘No Fault or Negligence’.

⁴ Under Article 13.2.3 of the World Anti-Doping Code, the IWF as the “relevant International Federation” of the athletes is a party with a right to appeal the decision.

⁵ An operative award provides the conclusion of the panel without providing the detailed reasoning for arriving at such conclusion.

Share

Cookie Policy & Privacy Notice

We use cookies on our website to personalize content, to analyze traffic on our website to provide social media features. We share your data with our analytics partners and social media content providers. Find out more

The privacy policy can be accessed here

Your current state: Consent rejected.


Accept Reject Read More